VALUE PLUS Trademark

Trademark Overview


On Friday, January 5, 2024, a trademark application was filed for VALUE PLUS with the United States Patent and Trademark Office. The USPTO has given the VALUE PLUS trademark a serial number of 98344169. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by Prime Therapeutics LLC. The VALUE PLUS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Pharmaceutical cost management services; medical cost management in the field of pharmaceuticals; business data analysis and reporting services in the fields of healthcare and pharmaceuticals, all for business purposes; business services provided to the healthcare industry, namely, the collection and reporting of data pertaining to pharmaceuticals for business purposes; business administration services, namely, negotiation of business contracts for others to enable government sponsored health care benefit programs to obtain discounts and refunds from drug manufacturers; providing information in the fields of business management of prescription drug savings, and business management of reduction of out-of-pocket costs and expenses for prescriptions; drug utilization review services
value plus

General Information


Serial Number98344169
Word MarkVALUE PLUS
Filing DateFriday, January 5, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Goods and ServicesPharmaceutical cost management services; medical cost management in the field of pharmaceuticals; business data analysis and reporting services in the fields of healthcare and pharmaceuticals, all for business purposes; business services provided to the healthcare industry, namely, the collection and reporting of data pertaining to pharmaceuticals for business purposes; business administration services, namely, negotiation of business contracts for others to enable government sponsored health care benefit programs to obtain discounts and refunds from drug manufacturers; providing information in the fields of business management of prescription drug savings, and business management of reduction of out-of-pocket costs and expenses for prescriptions; drug utilization review services

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePrime Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121

Party NamePrime Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEagan, MN 55121

Trademark Events


Event DateEvent Description
Friday, January 5, 2024NEW APPLICATION ENTERED
Tuesday, April 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 3, 2024ASSIGNED TO EXAMINER
Thursday, July 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 4, 2024NON-FINAL ACTION E-MAILED
Thursday, July 4, 2024NON-FINAL ACTION WRITTEN
Friday, July 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED